Dl-Penicillamine

Dl-Penicillamine

SCHEMBL21768465

CC(C)(S)C(N)C(=O)O.NC(CCS)C(=O)O

nearest known ligand 0.67

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS1 P23219 2/20 0.67
ALDH1A1 P00352 2/20 0.67
MAPT P10636 1/20 0.67
SLC7A11 Q9UPY5 1/20 0.43
GSR P00390 2/20 0.41
GRM8 O00222 1/20 0.41
GRM6 O15303 1/20 0.41
GRIN2D O15399 1/20 0.41
GRIN3B O60391 1/20 0.41
CYP1A2 P05177 1/20 0.41
GRIK1 P39086 1/20 0.41
GRM5 P41594 1/20 0.41
GRIA1 P42261 1/20 0.41
GRIA2 P42262 1/20 0.41
GRIA3 P42263 1/20 0.41
SLC1A3 P43003 1/20 0.41
SLC1A2 P43004 1/20 0.41
SLC1A1 P43005 1/20 0.41
GRIA4 P48058 1/20 0.41
GRIN1 Q05586 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Dl-Penicillamine SCHEMBL6333584 1.00 PTGS1 (0.67) PTGS1ALDH1A1MAPTSLC7A11GSR
Penicillamine SCHEMBL6333581 1.00 PTGS1 (0.67) PTGS1ALDH1A1MAPTSLC7A11GSR
Penicillamine SCHEMBL22124996 0.85 PTGS1 (0.72) PTGS1ALDH1A1MAPTSLC7A11GSR
Dl-Penicillamine SCHEMBL22124997 0.85 PTGS1 (0.72) PTGS1ALDH1A1MAPTSLC7A11GSR
Dl-Penicillamine SCHEMBL4261009 0.85 PTGS1 (0.72) PTGS1ALDH1A1MAPTSLC7A11GSR
Penicillamine SCHEMBL7170074 0.85 PTGS1 (0.72) PTGS1ALDH1A1MAPTSLC7A11GSR
Glutamic Acid SCHEMBL4261156 0.84 GRM8 (0.64) PTGS1ALDH1A1MAPTGSRGRM8
Penicillamine SCHEMBL11222229 0.83 PTGS1 (0.69) PTGS1ALDH1A1MAPTSLC7A11GSR
Dl-Penicillamine SCHEMBL16011677 0.82 ALDH1A1 (0.62) PTGS1ALDH1A1MAPTGSRCYP1A2
Penicillamine SCHEMBL16011676 0.82 ALDH1A1 (0.62) PTGS1ALDH1A1MAPTGSRCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113388007-A Ultra-pure agonists of guanylate cyclase C, methods of making and using the same 博士医疗爱尔兰有限公司 2021-09-14 CN disclosed
EP-2825188-B1 FORMULATIONS OF GUANYLATE CYCLASE C AGONISTS AND METHODS OF USE BAUSCH HEALTH IRELAND LTD (IE) 2020-03-04 EP disclosed
CN-108676076-A The method for preparing guanosine cyclic mono-phosphate agonist 辛纳吉制药公司 2018-10-19 CN disclosed
CN-107090016-A The method for preparing guanosine cyclic mono-phosphate activator 辛纳吉制药公司 2017-08-25 CN disclosed